Vivani Medical, Inc.
VANI
$1.13
$0.032.27%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 11.33% | -1.18% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.10% | 1.26% | |||
| Operating Income | -0.10% | -1.26% | |||
| Income Before Tax | -2.22% | -1.58% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.22% | -1.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.22% | -1.58% | |||
| EBIT | -0.10% | -1.26% | |||
| EBITDA | 0.12% | -1.13% | |||
| EPS Basic | 10.32% | 14.99% | |||
| Normalized Basic EPS | 10.33% | 15.06% | |||
| EPS Diluted | 55.87% | -72.76% | |||
| Normalized Diluted EPS | 10.33% | 15.06% | |||
| Average Basic Shares Outstanding | 13.89% | 19.51% | |||
| Average Diluted Shares Outstanding | 13.89% | 19.51% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||